Latest filing published 02 Sept 2020 for Aehr Test Systems, €20k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -25.8%Entry US$2.67 · Close at T+365 US$1.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Fucci: trading record in brief
David Fucci is a declared insider of Aehr Test Systems, with filings sourced from SEC (Form 4). We count 21 filings; the first trade dates from 24 November 2014 and the latest from 2 September 2020.
On the open market, the record shows 1 purchase worth €12k and 12 sales worth €72k. On balance, insiders were net sellers of €60k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants and 3 option exercises. So far in 2020, the count stands at no purchases and 5 sales.
The record was last updated on 2 September 2020 with an option exercise (€20k) in Aehr Test Systems. The most recent open-market purchase was published on 26 November 2014, 4,366 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Fucci
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,175 shares@ US$1.6832.4% of flowCommon StockSEC:0001654954-20-009779:0
- 4,791 shares@ US$1.6410.7% of flowCommon StockSEC:0001654954-20-009779:1
- 10,000 shares@ US$1.8024.5% of flowCommon StockSEC:0001654954-20-009779:2
- 8,966 shares@ US$1.8122.1% of flowCommon StockSEC:0001654954-20-009779:3
- 200 shares@ US$1.680.5% of flowCommon StockSEC:0001654954-20-009368:0
- 200 shares@ US$2.100.6% of flowCommon StockSEC:0001654954-20-009368:1
- 547 shares@ US$1.521.2% of flowCommon StockSEC:0001654954-20-005520:0
- 546 shares@ US$2.001.6% of flowCommon StockSEC:0001654954-20-001350:0
- 2,186 shares@ US$2.016.2% of flowCommon StockSEC:0001654954-19-012762:0
- 547 shares@ US$2.011.4% of flowCommon StockSEC:0001040470-18-000058:0
- 464 shares@ US$2.001.2% of flowCommon StockSEC:0001040470-18-000057:0
- 82 shares@ US$2.010.2% of flowCommon StockSEC:0001040470-18-000057:1
- 2,890 shares@ US$2.385.7% of flowCommon StockSEC:0001040470-18-000027:0
- 3,750 shares0Common StockSEC:0001040470-17-000044:0
- 7,618 shares@ US$2.8519.5% of flowCommon StockSEC:0001040470-17-000007:0
- 3,542 shares@ US$2.909.3% of flowCommon StockSEC:0001040470-17-000007:1
- 5,000 shares0Common StockSEC:0001040470-16-000110:0
- 2,443 shares@ US$0.9862.1% of flowCommon StockSEC:0001040470-16-000092:0
- 1,243 shares@ US$1.96Common StockSEC:0001040470-15-000072:0
- 1,304 shares@ US$1.96Common StockSEC:0001040470-15-000011:0
- 6,170 shares@ US$2.43Common StockSEC:0001040470-14-000088:0Canonical exit: 22 Feb 2015 (T+90)
21 of 21 declarations
